世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

腎性貧血治療薬の世界市場 2022-2026


Global Renal Anemia Therapeutics Market 2022-2026

腎性貧血治療薬の世界市場 2022-2026 年 Technavioは腎性貧血治療薬市場を監視しており、2022-2026年の間に19億7000万ドルの成長が見込まれ、予測期間中にCAGR 8.25%で加速しています。当レポートでは、腎性貧血... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年4月21日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報・注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

腎性貧血治療薬の世界市場 2022-2026 年
Technavioは腎性貧血治療薬市場を監視しており、2022-2026年の間に19億7000万ドルの成長が見込まれ、予測期間中にCAGR 8.25%で加速しています。当レポートでは、腎性貧血治療薬市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、CKD患者の大規模なプールの存在、新薬の承認、バイオシミラーの採用拡大によって牽引されています。
腎性貧血治療薬市場の分析には、用途別セグメントと地理的展望が含まれます。
Technavioの腎性貧血治療薬市場は、以下のように区分されています。
アプリケーション別
- 静脈注射
- 経口
地域別
- 北アメリカ
- 欧州
- アジア
- その他の地域(ROW)
本調査では、新興国におけるCKD透析センター数の増加が、今後数年間の腎性貧血治療薬市場の成長を促進する主要因の1つであると特定しています。また、ベンダー間の戦略的提携の事例が増加していることや、パイプラインにある薬剤の数が増加していることも、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細なイメージを提示します。腎性貧血治療薬市場に関する当レポートは、以下の分野を対象としています。
- 腎性貧血治療薬市場のサイジング
- 腎性貧血治療薬市場の予測
- 腎性貧血治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、AstraZeneca Plc、Akebia Therapeutics Inc、Amgen Inc、Bayer AG、Covis Pharma BV、第一三共株式会社、Dr. Reddyspharma BV、Technavi Co.(株)エフ・ホフマン・ラ・ロシュ、フィブロジェン(株)、グラクソ・スミスクライン・ピーエルシー、JCRファーマシューティカルズ(株)、JSCビオカード(株)Ltd.、JSC BIOCAD、Pfizer Inc.、Pharmacosmos ASの7社です。また、腎性貧血治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/renal-anemia-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 IV - Market size and forecast 2021-2026
o Exhibit 28: Chart on IV - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on IV - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on IV - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on IV - Year-over-year growth 2021-2026 (%)
o 5.4 Oral - Market size and forecast 2021-2026
o Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 85: AstraZeneca Plc - Overview
o Exhibit 86: AstraZeneca Plc - Product / Service
o Exhibit 87: AstraZeneca Plc - Key news
o Exhibit 88: AstraZeneca Plc - Key offerings
o 10.4 Akebia Therapeutics Inc.
o Exhibit 89: Akebia Therapeutics Inc. - Overview
o Exhibit 90: Akebia Therapeutics Inc. - Product / Service
o Exhibit 91: Akebia Therapeutics Inc. - Key offerings
o 10.5 Amgen Inc.
o Exhibit 92: Amgen Inc. - Overview
o Exhibit 93: Amgen Inc. - Product / Service
o Exhibit 94: Amgen Inc. - Key offerings
o 10.6 Bayer AG
o Exhibit 95: Bayer AG - Overview
o Exhibit 96: Bayer AG - Business segments
o Exhibit 97: Bayer AG - Key offerings
o Exhibit 98: Bayer AG - Segment focus
o 10.7 Covis Pharma BV
o Exhibit 99: Covis Pharma BV - Overview
o Exhibit 100: Covis Pharma BV - Product / Service
o Exhibit 101: Covis Pharma BV - Key offerings
o 10.8 Daiichi Sankyo Co. Ltd.
o Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.9 Dr. Reddys Laboratories Ltd.
o Exhibit 107: Dr. Reddys Laboratories Ltd. - Overview
o Exhibit 108: Dr. Reddys Laboratories Ltd. - Business segments
o Exhibit 109: Dr. Reddys Laboratories Ltd. - Key offerings
o Exhibit 110: Dr. Reddys Laboratories Ltd. - Segment focus
o 10.10 GlaxoSmithKline Plc
o Exhibit 111: GlaxoSmithKline Plc - Overview
o Exhibit 112: GlaxoSmithKline Plc - Business segments
o Exhibit 113: GlaxoSmithKline Plc - Key news
o Exhibit 114: GlaxoSmithKline Plc - Key offerings
o Exhibit 115: GlaxoSmithKline Plc - Segment focus
o 10.11 JSC BIOCAD
o Exhibit 116: JSC BIOCAD - Overview
o Exhibit 117: JSC BIOCAD - Product / Service
o Exhibit 118: JSC BIOCAD - Key offerings
o 10.12 Pharmacosmos AS
o Exhibit 119: Pharmacosmos AS - Overview
o Exhibit 120: Pharmacosmos AS - Product / Service
o Exhibit 121: Pharmacosmos AS - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 122: Inclusions checklist
o Exhibit 123: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 124: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 125: Research methodology
o Exhibit 126: Validation techniques employed for market sizing
o Exhibit 127: Information sources
o 11.5 List of abbreviations
o Exhibit 128: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on IV - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on IV - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on IV - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on IV - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AstraZeneca Plc - Overview
Exhibits86: AstraZeneca Plc - Product / Service
Exhibits87: AstraZeneca Plc - Key news
Exhibits88: AstraZeneca Plc - Key offerings
Exhibits89: Akebia Therapeutics Inc. - Overview
Exhibits90: Akebia Therapeutics Inc. - Product / Service
Exhibits91: Akebia Therapeutics Inc. - Key offerings
Exhibits92: Amgen Inc. - Overview
Exhibits93: Amgen Inc. - Product / Service
Exhibits94: Amgen Inc. - Key offerings
Exhibits95: Bayer AG - Overview
Exhibits96: Bayer AG - Business segments
Exhibits97: Bayer AG - Key offerings
Exhibits98: Bayer AG - Segment focus
Exhibits99: Covis Pharma BV - Overview
Exhibits100: Covis Pharma BV - Product / Service
Exhibits101: Covis Pharma BV - Key offerings
Exhibits102: Daiichi Sankyo Co. Ltd. - Overview
Exhibits103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits104: Daiichi Sankyo Co. Ltd. - Key news
Exhibits105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits107: Dr. Reddys Laboratories Ltd. - Overview
Exhibits108: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits109: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits110: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits111: GlaxoSmithKline Plc - Overview
Exhibits112: GlaxoSmithKline Plc - Business segments
Exhibits113: GlaxoSmithKline Plc - Key news
Exhibits114: GlaxoSmithKline Plc - Key offerings
Exhibits115: GlaxoSmithKline Plc - Segment focus
Exhibits116: JSC BIOCAD - Overview
Exhibits117: JSC BIOCAD - Product / Service
Exhibits118: JSC BIOCAD - Key offerings
Exhibits119: Pharmacosmos AS - Overview
Exhibits120: Pharmacosmos AS - Product / Service
Exhibits121: Pharmacosmos AS - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Renal Anemia Therapeutics Market 2022-2026
Technavio has been monitoring the renal anemia therapeutics market and it is poised to grow by $ 1.97 bn during 2022-2026, accelerating at a CAGR of 8.25% during the forecast period. Our report on the renal anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the presence of a large pool of CKD patients, new drug approvals, and the growing adoption of biosimilars.
The renal anemia therapeutics market analysis includes application segment and geographic landscape.
Technavio's renal anemia therapeutics market is segmented as below:
By Application
• IV
• Oral
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing number of CKD dialysis centers in emerging economies as one of the prime reasons driving the renal anemia therapeutics market growth during the next few years. Also, increasing instances of strategic collaborations among vendors and a rising number of drugs in the pipeline will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the renal anemia therapeutics market covers the following areas:
• Renal anemia therapeutics market sizing
• Renal anemia therapeutics market forecast
• Renal anemia therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading renal anemia therapeutics market vendors that include AstraZeneca Plc, Akebia Therapeutics Inc., Amgen Inc., Bayer AG, Covis Pharma BV, Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., FibroGen Inc., GlaxoSmithKline Plc, JCR Pharmaceuticals Co. Ltd., JSC BIOCAD, Pfizer Inc., and Pharmacosmos AS. Also, the renal anemia therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/renal-anemia-therapeutics-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Application
o 5.1 Market segments
o Exhibit 24: Chart on Application - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
o 5.2 Comparison by Application
o Exhibit 26: Chart on Comparison by Application
o Exhibit 27: Data Table on Comparison by Application
o 5.3 IV - Market size and forecast 2021-2026
o Exhibit 28: Chart on IV - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on IV - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on IV - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on IV - Year-over-year growth 2021-2026 (%)
o 5.4 Oral - Market size and forecast 2021-2026
o Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Application
o Exhibit 36: Market opportunity by Application ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share by geography 2021-2026 (%)
o Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity by geography
o Exhibit 78: Market opportunity by geography ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 AstraZeneca Plc
o Exhibit 85: AstraZeneca Plc - Overview
o Exhibit 86: AstraZeneca Plc - Product / Service
o Exhibit 87: AstraZeneca Plc - Key news
o Exhibit 88: AstraZeneca Plc - Key offerings
o 10.4 Akebia Therapeutics Inc.
o Exhibit 89: Akebia Therapeutics Inc. - Overview
o Exhibit 90: Akebia Therapeutics Inc. - Product / Service
o Exhibit 91: Akebia Therapeutics Inc. - Key offerings
o 10.5 Amgen Inc.
o Exhibit 92: Amgen Inc. - Overview
o Exhibit 93: Amgen Inc. - Product / Service
o Exhibit 94: Amgen Inc. - Key offerings
o 10.6 Bayer AG
o Exhibit 95: Bayer AG - Overview
o Exhibit 96: Bayer AG - Business segments
o Exhibit 97: Bayer AG - Key offerings
o Exhibit 98: Bayer AG - Segment focus
o 10.7 Covis Pharma BV
o Exhibit 99: Covis Pharma BV - Overview
o Exhibit 100: Covis Pharma BV - Product / Service
o Exhibit 101: Covis Pharma BV - Key offerings
o 10.8 Daiichi Sankyo Co. Ltd.
o Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.9 Dr. Reddys Laboratories Ltd.
o Exhibit 107: Dr. Reddys Laboratories Ltd. - Overview
o Exhibit 108: Dr. Reddys Laboratories Ltd. - Business segments
o Exhibit 109: Dr. Reddys Laboratories Ltd. - Key offerings
o Exhibit 110: Dr. Reddys Laboratories Ltd. - Segment focus
o 10.10 GlaxoSmithKline Plc
o Exhibit 111: GlaxoSmithKline Plc - Overview
o Exhibit 112: GlaxoSmithKline Plc - Business segments
o Exhibit 113: GlaxoSmithKline Plc - Key news
o Exhibit 114: GlaxoSmithKline Plc - Key offerings
o Exhibit 115: GlaxoSmithKline Plc - Segment focus
o 10.11 JSC BIOCAD
o Exhibit 116: JSC BIOCAD - Overview
o Exhibit 117: JSC BIOCAD - Product / Service
o Exhibit 118: JSC BIOCAD - Key offerings
o 10.12 Pharmacosmos AS
o Exhibit 119: Pharmacosmos AS - Overview
o Exhibit 120: Pharmacosmos AS - Product / Service
o Exhibit 121: Pharmacosmos AS - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 122: Inclusions checklist
o Exhibit 123: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 124: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 125: Research methodology
o Exhibit 126: Validation techniques employed for market sizing
o Exhibit 127: Information sources
o 11.5 List of abbreviations
o Exhibit 128: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Application - Market share 2021-2026 (%)
Exhibits25: Data Table on Application - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Application
Exhibits27: Data Table on Comparison by Application
Exhibits28: Chart on IV - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on IV - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on IV - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on IV - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Application ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share by geography 2021-2026 (%)
Exhibits39: Data Table on Market share by geography 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity by geography ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: AstraZeneca Plc - Overview
Exhibits86: AstraZeneca Plc - Product / Service
Exhibits87: AstraZeneca Plc - Key news
Exhibits88: AstraZeneca Plc - Key offerings
Exhibits89: Akebia Therapeutics Inc. - Overview
Exhibits90: Akebia Therapeutics Inc. - Product / Service
Exhibits91: Akebia Therapeutics Inc. - Key offerings
Exhibits92: Amgen Inc. - Overview
Exhibits93: Amgen Inc. - Product / Service
Exhibits94: Amgen Inc. - Key offerings
Exhibits95: Bayer AG - Overview
Exhibits96: Bayer AG - Business segments
Exhibits97: Bayer AG - Key offerings
Exhibits98: Bayer AG - Segment focus
Exhibits99: Covis Pharma BV - Overview
Exhibits100: Covis Pharma BV - Product / Service
Exhibits101: Covis Pharma BV - Key offerings
Exhibits102: Daiichi Sankyo Co. Ltd. - Overview
Exhibits103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits104: Daiichi Sankyo Co. Ltd. - Key news
Exhibits105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits107: Dr. Reddys Laboratories Ltd. - Overview
Exhibits108: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits109: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits110: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits111: GlaxoSmithKline Plc - Overview
Exhibits112: GlaxoSmithKline Plc - Business segments
Exhibits113: GlaxoSmithKline Plc - Key news
Exhibits114: GlaxoSmithKline Plc - Key offerings
Exhibits115: GlaxoSmithKline Plc - Segment focus
Exhibits116: JSC BIOCAD - Overview
Exhibits117: JSC BIOCAD - Product / Service
Exhibits118: JSC BIOCAD - Key offerings
Exhibits119: Pharmacosmos AS - Overview
Exhibits120: Pharmacosmos AS - Product / Service
Exhibits121: Pharmacosmos AS - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(その他)の最新刊レポート


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/09/19 10:28

144.64 円

160.77 円

193.27 円

ページTOPに戻る